Sabine Charrier

2.9k citations

38 papers · 1.9k indexed · h-index 20

Genetics top 2%
- Virus-based gene therapy research 14
Immunology top 5%
Oncology top 5%
- CAR-T cell therapy research 11
- Cancer Treatment and Pharmacology 6
Cancer Research top 10%
- Breast Cancer Treatment Studies 7
Hematology top 5%
- Hematopoietic Stem Cell Transplantation 4
Molecular Biology
- RNA Interference and Gene Delivery 8
- CRISPR and Genetic Engineering 4
Pathology and Forensic Medicine
- Breast Lesions and Carcinomas 4

Co-authors: Anne Galy William Vainchenker Adrian J. Thrasher Axel Schambach Juan A. Bueren J Dauplat Susana Navarro Ute Modlich
Cited by: Genetics Immunology Oncology
Journals: Blood (5 papers)PLoS ONE (1 paper)American Journal of Physiology-Endocrinology and Metabolism (1 paper)
Partner nations: France Germany United Kingdom

In The Last Decade

Sabine Charrier

36 papers receiving 1.8k citations

Peers

Countries citing papers authored by Sabine Charrier

Since Specialization

Citations

This map shows the geographic impact of Sabine Charrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Charrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Charrier more than expected).

Fields of papers citing papers by Sabine Charrier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Charrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Charrier. The network helps show where Sabine Charrier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sabine Charrier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sabine Charrier Line = papers co-authored together Sabine Charrier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease PubMed ·Christian Brendel,Michael Rothe,Giorgia Santilli,Sabine Charrier,Stefan Stein,Hana Kunkel,Daniela Abriss,Uta Müller-Kuller,Bobby Gaspar,Ute Modlich,Anne Galy,Axel Schambach,Adrian J. Thrasher,Manuel Grez	2018	28
2	Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency Molecular Therapy — Methods & Clinical Development ·Valentina Poletti,Sabine Charrier,Guillaume Corre,Bernard Gjata,Alban Vignaud,Fang Zhang,Michael Rothe,Axel Schambach,H. Bobby Gaspar,Adrian J. Thrasher,Fulvio Mavilio	2018	33
3	Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients Blood ·Paula Rı́o,Susana Navarro,Guillermo Güenechea,Rebeca Sánchez‐Domínguez,María L. Lamana,Rosa María Pérez Yáñez,José Antonio Casado,Parinda A. Mehta,María Roser Pujol,Jordi Surrallés,Sabine Charrier,Anne Galy,José C. Segovia,Cristina Díaz de Heredia,Julián Sevilla,Juan A. Bueren	2017	42
4	Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs Current Gene Therapy ·Francisco J. Molina-Estévez,Ali Nowrouzi,M. Luz Lozano,Anne Galy,Sabine Charrier,Christof von Kalle,Guillermo Güenechea,Juan A. Bueren,Manfred Schmidt	2015	18
5	Lymphopoiesis in transgenic mice over-expressing Artemis Gene Therapy ·Paola Rivera-Muñoz,Vincent Abramowski,Serge Jacquot,Pascale André,Sabine Charrier,Karelia Lipson-Ruffert,Alain Fischer,Anne Galy,Marina Cavazzana,Jean‐Pierre de Villartay	2015	6
6	Wiskott-Aldrich syndrome protein-deficient hematopoietic cells can be efficiently mobilized by granulocyte colony-stimulating factor Haematologica ·Sabine Charrier,Michael P. Blundell,Grégory Cédrone,Fawzia Louache,William Vainchenker,Adrian J. Thrasher,Anne Galy	2013	6
7	A major role of TGF-β1 in the homing capacities of murine hematopoietic stem cell/progenitors Blood ·Claude Capron,Catherine Lacout,Yann Lécluse,Valérie Jalbert,Hédia Chagraoui,Sabine Charrier,Anne Galy,Annelise Bennaceur‐Griscelli,Elisabeth M. Cramer,William Vainchenker	2010	31
8	Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction Gene Therapy ·Sabine Charrier,Marina Ferrand,Madeleine Zerbato,Guillaume Précigout,A Viornery,S Bucher-Laurent,Sofia Benkhelifa‐Ziyyat,Otto‐Wilhelm Merten,Javier Perea,Anne Galy	2010	72
9	Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott–Aldrich syndrome The Journal of Gene Medicine ·Julie Mantovani,Sabine Charrier,Ralph Eckenberg,William Saurin,Olivier Danos,Javier Perea,Anne Galy	2009	13
10	Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS Gene Therapy ·Maria Antonietta Zanta-Boussif,Sabine Charrier,A Brice-Ouzet,Susan S. Martin,Paule Opolon,Adrian J. Thrasher,Thomas J. Hope,Anne Galy	2009	58
11	Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors Molecular Therapy ·Ute Modlich,Susana Navarro,Daniela Zychlinski,Tobias Maetzig,Sabine Knoess,Martijn H. Brugman,Axel Schambach,Sabine Charrier,Anne Galy,Adrian J. Thrasher,Juan A. Bueren,Christopher Baum	2009	289
12	Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients Gene Therapy ·Sabine Charrier,Loı̈c Dupré,Samantha Scaramuzza,Laurence Jeanson-Leh,Michael P. Blundell,Olivier Danos,Federica Cattaneo,Alessandro Aiuti,Ralph Eckenberg,A J Thrasher,Maria Grazia Roncarolo,Anne Galy	2006	79
13	A Partial Down-regulation of WASP Is Sufficient to Inhibit Podosome Formation in Dendritic Cells Molecular Therapy ·Aurélie Olivier,Laurence Jeanson-Leh,Gerben Bouma,Daniel Compagno,Johanna Blondeau,Khalil Seye,Sabine Charrier,Siobhan O. Burns,Adrian J. Thrasher,Olivier Danos,William Vainchenker,Anne Galy	2005	39
14	Recurrent V75M mutation within the Wiskott–Aldrich syndrome protein: description of a homozygous female patient European Journal Of Haematology ·Alexis Proust,Benoît Guillet,Isabelle Pellier,Petronela Rachieru,C. Hoarau,S. Claeyssens,Claude Léonard,Sabine Charrier,William Vainchenker,Gil Tchernia,J. Delaunay	2005	7
15	A lentiviral vector encoding the human Wiskott–Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice Gene Therapy ·Sabine Charrier,Daniel Stockholm,Khalil Seye,Paule Opolon,Mathieu Taveau,David‐Alexandre Gross,S Bucher-Laurent,Christophe Delenda,William Vainchenker,Olivier Danos,Anne Galy	2004	98
16	High-Dose Plasma Infusion versus Plasma Exchange as Early Treatment of Thrombotic Thrombocytopenic Purpura/Hemolytic-Uremic Syndrome Medicine ·Paul Coppo,A Bussel,Sabine Charrier,Christophe Adrie,Lionel Galicier,Emmanuelle Boulanger,Agnès Veyradier,Thierry Leblanc,Corinne Alberti,Élie Azoulay,Jean‐Roger Le Gall,Benoı̂t Schlemmer	2003	82
17	CD34+CDw90(Thy-1)+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells Experimental Hematology ·Nathalie Boiret,Chantal Rapatel,Stéphane Boisgard,Sabine Charrier,Andréï Tchirkov,Caroline Bresson,Lionel Camilleri,Juliette Berger,Laurent Guillouard,Jean‐Jacques Guérin,Pascale Pigeon,J Chassagne,Marc Berger	2003	19
18	Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer Bone Marrow Transplantation ·Sabine Charrier,P. Chollet,J.-O. Bay,H. Curé,Fabrice Kwiatkowski,G. Portefaix,Yves Communal,G Bétail,R Plagne,J Chassagne	2000	2
19	Chrono-pharmacocinétique du 5-fluoro-uracile dans le traitement des cancers colorectaux métastatiques et indicateurs de réponse métabolique Journal de Pharmacie Clinique ·Fabrice Kwiatkowski,R. Chevrier,J.-P. De Renzis,Sabine Charrier,H. Curé,P.J. Bargnoux,A. Léger-Enreille,P. Chollet	1999	1
20	Mobilization of peripheral blood progenitor cells after induction chemotherapy (THP-doxorubicin-vinorelbine-cyclophosphamide-fluorouracil) and granulocyte colony-stimulating factor in breast cancer Bone Marrow Transplantation ·Sabine Charrier,J Chassagne,H. Curé,J-O Bay,Yves Communal,G. Portefaix,J-P Ferrière,G Bétail,R Plagne,P. Chollet	1998	4

About Sabine Charrier

Sabine Charrier is a scholar working on Oncology, Genetics and Cancer Research, having authored 38 papers that have together received 1.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (11 papers), RNA Interference and Gene Delivery (8 papers), Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (6 papers), CRISPR and Genetic Engineering (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Breast Lesions and Carcinomas (4 papers). The work is most often cited by research in Genetics (755 citations), Immunology (432 citations) and Oncology (529 citations). Sabine Charrier has collaborated with scholars based in France, Germany and United Kingdom. Frequent co-authors include Anne Galy, William Vainchenker, Adrian J. Thrasher, Axel Schambach, Juan A. Bueren, J Dauplat, Susana Navarro, Ute Modlich, Daniela Zychlinski and Sabine Knoess. Their work appears in journals such as Blood, PLoS ONE and American Journal of Physiology-Endocrinology and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact